other material
confidence high
sentiment neutral
materiality 0.25
Sonoma Pharma grants 7,500 options to directors and 10,000 RSUs to each top executive
Sonoma Pharmaceuticals, Inc.
- Non-employee directors each received 7,500 options at $2.68, vesting over three years.
- CEO Amy Trombly granted 10,000 RSUs; vesting at 6, 18, and 24 months.
- CFO Jerry Dvonch and COO Bruce Thornton each granted 10,000 RSUs with same vesting schedule.
- All awards vest upon change of control as part of annual equity grant program.